Permax and retroperitoneal fibrosis Patient Reports February 12, 2012

Permax Side Effects Report #4713638-9
Permax side effect was reported by a Physician from BELGIUM on June 24, 2005. Male patient, 74 years of age, weighting 187.4 lb, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: hydronephrosis, retroperitoneal fibrosis. Permax dosage: 0.25 MG/3 DAY. During the same period patient was treated with PROLOPA. Patient recovered.

Permax Side Effects Report #4642869-1
Permax side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Male patient, 65 years of age, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: hydronephrosis, obstructive uropathy, oedema peripheral, renal failure, retroperitoneal fibrosis, ureteric stenosis. Permax dosage: 1 MG/3 DAY. During the same period patient was treated with NAKOM, SINEMET. Patient was hospitalized. Patient recovered.

Permax Side Effects Report #5248217-0
Permax side effect was reported by a Physician from DENMARK on Jan 26, 2007. Female patient, 61 years of age, weighting 154.3 lb, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: hydronephrosis, retroperitoneal fibrosis. Permax dosage: 3 MG; QD; PO. During the same period patient was treated with CARBIDOPA AND LEVODOPA, ENDO LEVODOPA, PRAMIPEXOLE DIHYDROCHLORIDE. Patient recovered.

Permax Side Effects Report #5129327-5
Permax side effect was reported by a Physician from DENMARK on Sept 29, 2006. Female patient, 61 years of age, weighting 154.3 lb, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: hydronephrosis, retroperitoneal fibrosis. Permax dosage: 3 MG; QD; PO. During the same period patient was treated with CARBIDOPA AND LEVODOPA, ENDO LEVODOPA, PRAMIPEXOLE DIHYDROCHLORIDE. Patient recovered.


Permax Side Effects Report #5473234-5
Permax side effect was reported by a Consumer or non-health professional from ITALY on Sept 18, 2007. Male patient, 54 years of age, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: retroperitoneal fibrosis, urethral stenosis. Permax dosage: 4 MG; QD; PO. Patient was hospitalized. Patient recovered.

Permax Side Effects Report #5483160-3
Permax side effect was reported by a Consumer or non-health professional from ITALY on Oct 03, 2007. Male patient, 54 years of age, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: retroperitoneal fibrosis. Permax dosage: 4 MG;QD;PO. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient recovered.